Name: Cardio-Renal-Metabolic Disease
Brand: Nextechoasis
SKU: 27127

Description

This immersive VR case study places the learner in a clinical scenario involving a patient with type 2 diabetes mellitus complicated by cardio-renal-metabolic (CRM) disease.

Through three interactive visits, learners assess patient data, interpret laboratory and diagnostic findings, and apply integrated management strategies in accordance with ADA 2024, KDIGO, ESC, and ACC/AHA guidelines.

The module reinforces decision-making in managing overlapping cardiovascular, renal, and metabolic disorders using evidence-based therapies such as SGLT2 inhibitors, RAS blockade, and heart failure optimization principles.

Learning objectives

Recognize the interrelationship between cardiovascular, renal, and metabolic dysfunction in patients with type 2 diabetes.
Interpret diagnostic parameters such as eGFR, UACR, BNP, and troponin to classify disease severity and progression.
Apply current clinical guidelines (ADA 2024, KDIGO, ESC, ACC/AHA) to formulate a comprehensive, patient-centered treatment plan.
Select and optimize pharmacologic therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, ARNI, MRA, and statins, for cardio-renal protection.
Integrate multidisciplinary management approaches to reduce hospitalization, improve outcomes, and slow disease progression in CRM conditions.